Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase igf1r'

Search results for: 'research area tyrosine kinase igf1r'

Items 291-300 of 777

Page
per page
  1. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  2. PIM-1 Inhibitor 2
    A4519 PIM-1 Inhibitor 2
    Summary: Potent Pim-1 kinase inhibitor
      Soluble in DMSO
  3. WHI-P154
    A4150 WHI-P154
    Target: VEGFR|Src|EGFR|JAK
    Summary: JAK3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥125.6 mg/mL
  4. Btk inhibitor 1 R enantiomer
    B3243 Btk inhibitor 1 R enantiomer
    Summary: Btk kinase inhibitor
      Soluble in DMSO
  5. Tofacitinib (CP-690550,Tasocitinib)
    A4138 Tofacitinib (CP-690550,Tasocitinib)
     1 Citation
    Target: JAK
    Summary: Janus kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.6 mg/mL
  6. NH125
    A8814 NH125
     1 Citation
    Target: eEF-2
    Summary: Selective eEF-2 kinase inhibitor
      ≥25.9 mg/mL
  7. AS 602801
    A3189 AS 602801
    Summary: Jun Kinase Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL
  8. MLN120B
    A3628 MLN120B
    Summary: IκB Kinase β Inhibitor
      insoluble in H2O; ≥13.2 mg/mL
  9. LKB1 (AAK1 dual inhibitor)
    A3556 LKB1 (AAK1 dual inhibitor)
    Target: Pim
    Summary: Pim-1 kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥34.8 mg/mL
  10. ABC294640
    B1182 ABC294640
    Target: SK
    Summary: Sphingosine kinase 2 inhibitor,selective and competitive
      ≥38.1 mg/mL

Items 291-300 of 777

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways 656item
  2. Natural Products 6item
  3. Protein 12item
  4. Kits 7item
  5. Screening Library 32item
  6. Peptides 2item
  7. Probes & Dyes 1 item
  8. Cell Biology 4item
  9. Peptides & Proteins 51item
  10. Protein & Immunology 7item
  11. Lab Reagents 1 item
Specificity
  1. Selective 245item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 24item
  2. Irreversible 8item
Target
  1. Cyclin-Dependent Kinases 27item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 4item
  4. PI3K 16item
  5. Raf 10item
  6. Aurora Kinases 21item
  7. CSF-1R 4item
  8. mTOR 8item
  9. FLT3 13item
  10. GSK-3 9item
  11. PLK 6item
  12. Chk 5item
  13. Eph Receptors 3item
  14. VEGFR 30item
  15. PDGFR 22item
  16. c-Kit 12item
  17. RET 4item
  18. IRAK 3item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 6item
  21. PKB 1 item
  22. JNK 2item
  23. SGK 2item
  24. Bcr-Abl 13item
  25. MEK 4item
  26. FGFR 12item
  27. Insulin-like growth factor receptors(IGFRs) 1 item
  28. Pim 4item
  29. Voltage-gated Sodium (NaV) Channels 1 item
  30. Ribosomal s6 kinases (RSK) 1 item
  31. MET 5item
  32. Src 17item
  33. Trk Receptors 3item
  34. STAT 3item
  35. EGFR 19item
  36. ROCK 7item
  37. BTK 1 item
  38. PAK 3item
  39. FAK 4item
  40. BMP and Other Activin Receptors 2item
  41. JAK 16item
  42. Syk 5item
  43. DNA-PK 5item
  44. AMPK 2item
  45. PDHK 1 item
  46. Cytochrome P450 (CYP450) 1 item
  47. ErbB 4item
  48. S6 kinases 1 item
  49. Adenosine Kinases 2item
  50. ERK 4item
  51. Kinases 1 item
  52. c-MET 5item
  53. PKC 12item
  54. Ubiquitin-specific proteases 1 item
  55. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  56. Lyn 2item
  57. HER2 2item
  58. Pyk2 3item
  59. LRRK2 5item
  60. Insulin and Insulin-like Receptors 3item
  61. ALK 6item
  62. ROS1 1 item
  63. Sphingosine kinases (SphKs) 2item
  64. PKG 2item
  65. PKA 5item
  66. Myosin light chain kinases (MLCKs) 2item
  67. CaM-KK 1 item
  68. MELK 1 item
  69. Insulin-like growth factors (IGFs) 1 item
  70. Clk 1 item
  71. NUAK1 1 item
  72. NUAK2 1 item
  73. MK2 2item
  74. Fatty-acid-binding proteins (FABPs) 1 item
  75. Angiotensin-Converting Enzymes (ACEs) 1 item
  76. Tie-2 2item
  77. RSK 2item
  78. phosphatases 1 item
  79. ATM/ATR 4item
  80. CK1 1 item
  81. Farnesyl Diphosphate Synthases 1 item
  82. CK2 3item
  83. HIPK2 1 item
  84. HIPK3 1 item
  85. P2X Receptors 1 item
  86. c-Fyn 1 item
  87. TAK1 1 item
  88. Histamine H1 Receptors 1 item
  89. P110 1 item
  90. Hck 2item
  91. MNK 1 item
  92. 5-Lipoxygenases 1 item
  93. Insulin Receptors 1 item
  94. IRG-1R 1 item
  95. Cdc2-like kinase (Clk) 1 item
  96. eEF-2 1 item
  97. Cdc7 1 item
  98. ZAP-70 1 item
  99. c-RET 3item
  100. p70 rsk 2item
  101. VEGFR3/FLT4 1 item
  102. NTRK1/TRKA 1 item
  103. CSF-1R/c-Fms 1 item
  104. TAM kinase 1 item
  105. KDR 1 item
  106. Fyn kinase 1 item
  107. Abl kinases 1 item
  108. AXL 1 item
  109. c-Fms tyrosine kinase 1 item
  110. insulin 1 item
  111. haspin kinase 1 item
  112. STK 1 item
  113. MSK 1 item
  114. Lyn kinase 1 item
  115. Mer tyrosine kinase 1 item
  116. ErbB-2 1 item
  117. PDK-1 1 item
  118. Histone Acetyltransferases (HATs) 1 item
  119. Prk 1 item
  120. ITK 1 item
  121. NUAK 1 item
  122. DCLK2 1 item
  123. PTK 1 item
  124. phosphatidylinositol kinase 1 item
  125. Lck 1 item
  126. Flk1 2item
  127. Protein Tyrosine Phosphatases 1 item
  128. alkaline phosphatases 1 item
  129. ATPases 1 item
  130. glutamate release 1 item
  131. FGR 1 item
  132. YES 2item
  133. Fyn 2item
  134. ARG 1 item
  135. TRPC channel 1 item
  136. PKD 1 item
  137. Pyruvate kinases 1 item
  138. enoyl-acyl-carrier protein reductase 1 item
  139. Rho-kinase 1 item
  140. tropomyosin receptor kinase 1 item
  141. SK 1 item
  142. PPK 1 item
  143. c-Syk 1 item
  144. CDK1/CyclinB 1 item
  145. PIM1 kinase 1 item
  146. phospholipase A2 1 item
  147. ATM 1 item
  148. PIKfyve 1 item
  149. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 284item
  2. Cell Experiments 211item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 44item
  9. Cancer 198item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 20item
  15. Colon Carcinoma 3item
  16. Colorectal Cancer 19item
  17. Diabetes 1 item
  18. Glioblastoma 17item
  19. Glioma 6item
  20. Hepatocellular Carcinoma 4item
  21. HIV Infections 1 item
  22. Immunological Diseases 1 item
  23. Inflammatory Bowel Disease 1 item
  24. Inflammatory Diseases 4item
  25. Leukemia 8item
  26. Liver Cancer 3item
  27. Lung Cancer 15item
  28. Lung Carcinoma 3item
  29. Lymphoma 9item
  30. Mantle Cell Lymphoma 1 item
  31. Melanoma 12item
  32. Multiple Myeloma 6item
  33. Myelofibrosis 1 item
  34. Myeloma 2item
  35. Neuroblastoma 2item
  36. Non-small Cell Lung Cancer 6item
  37. Non-small Cell Lung Carcinoma 1 item
  38. Ovarian Cancer 14item
  39. Pancreatic Cancer 22item
  40. Prostate Cancer 17item
  41. Psoriasis 1 item
  42. Pulmonary Arterial Hypertension 1 item
  43. Renal Cancer 3item
  44. Renal Cell Carcinoma 5item
  45. Rheumatoid Arthritis 5item
  46. Thyroid Cancer 5item
  47. Type 2 Diabetes 3item